There is a noticeable variation in the achievement of LDL cholesterol targets between different European countries, Dr Gitt revealed. "However the effect of different reimbursement systems on meeting the targets was unknown." Between June 2008 and February 2009 DYSIS assessed the prevalence and types of persistent lipid abnormalities in patients receiving statins. Eligible patients were at high risk of a cardiovascular event, aged 45 years, and had been on chronic ...
Read More
No comments:
Post a Comment